• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases

 
Select:
Jun 28, 2005
Elite Pharmaceuticals Announces Agreement for the Development of a Controlled Release Product

Jun 22, 2005
Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product

May 26, 2005
FDA Approves IND for Elite Pharmaceuticals Abuse-Resistant Oxycodone Product

Apr 26, 2005
Elite Pharmaceuticals Announces IND Filing for Abuse-Resistant Technology for Narcotic Analgesics

Apr 05, 2005
Elite Laboratories Announces Agreement For Development, Manufacture and Distribution of a Controlled Release Product

Mar 09, 2005
Elite Pharmaceuticals Announces Conversion of All Outstanding Series A Preferred Stock Into Common Stock

Jan 25, 2005
Elite Pharmaceuticals Announces Election of New Director to its Board and Date of Annual Stockholders Meeting

Nov 04, 2004
Elite Pharmaceuticals Completes Preferred Stock Private Placement and Raised a Total of $6.6 Million

Oct 28, 2004
Elite Pharmaceuticals Acknowledges Sale in Private Transaction by Former Controlling Shareholder

Oct 12, 2004
Elite Pharmaceuticals Completes $4.6 Million Private Placement

 24   25   26   27   28     29    30   31 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window